US Stock MarketDetailed Quotes

INO Inovio Pharmaceuticals

Watchlist
  • 5.5400
  • +0.0200+0.36%
Close Nov 8 16:00 ET
  • 5.5400
  • 0.00000.00%
Post 20:01 ET
143.84MMarket Cap-1092P/E (TTM)

Inovio Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Inovio Pharmaceuticals Q3 2024 Estimates Date

Currency：USDNov 14, 2024

Estimate YoY
Revenue
104.50K
-73.10%
EPS
-1.15
+26.28%
Analyst Rating
Buy

Nov 8, 2024

Inovio Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 121.200K--
Nov 14, 20242024/Q3-- / 104.500K--
Aug 8, 20242024/Q2100.760K / 121.500K--
May 13, 20242024/Q10.000 / 150.800K--
Mar 6, 20242023/Q4102.650K / 344.120K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 121.200K--
Nov 14, 20242024/Q3-- / 104.500K--
Aug 8, 20242024/Q2100.760K / 121.500K--
May 13, 20242024/Q10.000 / 150.800K--
Mar 6, 20242023/Q4102.650K / 344.120K--

Unlock Free Earnings Estimates

Inovio Pharmaceuticals Earnings Reports

  • Inovio Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 8 16:14 ET

  • Inovio Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 13 16:05 ET

  • Inovio Pharmaceuticals | 10-K: FY2023 Annual Report

    Mar 6 16:06 ET

  • Inovio Pharmaceuticals | 10-Q: Q3 2023 Earnings Report

    Nov 9, 2023 16:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 8, 2024

    Buy

    • Buy

      50.00%

    • Hold

      50.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data

    Concept Mpox (monkeypox)
    Mpox (monkeypox)
    Intraday-0.45%